WO2009036753A3 - Novel pharmaceuticals, method for the production thereof and use thereof in medical therapy - Google Patents

Novel pharmaceuticals, method for the production thereof and use thereof in medical therapy Download PDF

Info

Publication number
WO2009036753A3
WO2009036753A3 PCT/DE2008/001566 DE2008001566W WO2009036753A3 WO 2009036753 A3 WO2009036753 A3 WO 2009036753A3 DE 2008001566 W DE2008001566 W DE 2008001566W WO 2009036753 A3 WO2009036753 A3 WO 2009036753A3
Authority
WO
WIPO (PCT)
Prior art keywords
production
medical therapy
novel pharmaceuticals
novel
pharmaceuticals
Prior art date
Application number
PCT/DE2008/001566
Other languages
German (de)
French (fr)
Other versions
WO2009036753A2 (en
Inventor
Hans Scheefers
Original Assignee
Schebo Biotech Ag
Hans Scheefers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schebo Biotech Ag, Hans Scheefers filed Critical Schebo Biotech Ag
Publication of WO2009036753A2 publication Critical patent/WO2009036753A2/en
Publication of WO2009036753A3 publication Critical patent/WO2009036753A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to novel pharmaceuticals based on novel substituted 4-pyridine-3yl-pyrimidine, to a method for the production thereof, and to the use thereof in medical therapy, in particular cancer diseases.
PCT/DE2008/001566 2007-09-20 2008-09-19 Novel pharmaceuticals, method for the production thereof and use thereof in medical therapy WO2009036753A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007046266 2007-09-20
DE102007046266.4 2007-09-20

Publications (2)

Publication Number Publication Date
WO2009036753A2 WO2009036753A2 (en) 2009-03-26
WO2009036753A3 true WO2009036753A3 (en) 2009-05-07

Family

ID=40379649

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2008/001566 WO2009036753A2 (en) 2007-09-20 2008-09-19 Novel pharmaceuticals, method for the production thereof and use thereof in medical therapy

Country Status (1)

Country Link
WO (1) WO2009036753A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009019852A1 (en) 2009-05-06 2010-11-11 Schebo Biotech Ag New polymer compound comprising amine structural elements, useful as synthetic resins, coatings, foams, liquid crystals, adhesives, paints, varnishes, composite materials, in cosmetics, and in polymer electronics

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040224967A1 (en) * 2003-05-02 2004-11-11 Chen Guoqing P Phenylaminopyrimidine derivatives and methods of use
US20040248918A1 (en) * 2003-05-06 2004-12-09 Il Yang Pharm. Co., Ltd. N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
WO2005058320A1 (en) * 2003-12-19 2005-06-30 Novartis Ag COMBINATION OF (a) N-{5-[4-(4-METHYL-PIPERAZINO-METHYL)-BENZOYLAMIDO]-2METHYLPHENYL}-4-(3-PYRIDYL)-2-PYRIMIDINE-AMINE AND (b) AT LEAST ONE HYPUSINATION INHIBITOR AND THE USE THEREOF
WO2005075454A2 (en) * 2004-02-04 2005-08-18 Novartis Ag SALT FORMS OF 4-(4-METHYLPIPERAZIN-1-YLMETHYL)-n-[4-METHYL-3-(4-PYRIDIN-3-YL)PYRIMIDIN-2-YLAMINO)PHENYL]-BENZAMIDE
WO2006021458A2 (en) * 2004-08-27 2006-03-02 Gpc Biotech Ag Pyrimidine derivatives

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040224967A1 (en) * 2003-05-02 2004-11-11 Chen Guoqing P Phenylaminopyrimidine derivatives and methods of use
US20040248918A1 (en) * 2003-05-06 2004-12-09 Il Yang Pharm. Co., Ltd. N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
WO2005058320A1 (en) * 2003-12-19 2005-06-30 Novartis Ag COMBINATION OF (a) N-{5-[4-(4-METHYL-PIPERAZINO-METHYL)-BENZOYLAMIDO]-2METHYLPHENYL}-4-(3-PYRIDYL)-2-PYRIMIDINE-AMINE AND (b) AT LEAST ONE HYPUSINATION INHIBITOR AND THE USE THEREOF
WO2005075454A2 (en) * 2004-02-04 2005-08-18 Novartis Ag SALT FORMS OF 4-(4-METHYLPIPERAZIN-1-YLMETHYL)-n-[4-METHYL-3-(4-PYRIDIN-3-YL)PYRIMIDIN-2-YLAMINO)PHENYL]-BENZAMIDE
WO2006021458A2 (en) * 2004-08-27 2006-03-02 Gpc Biotech Ag Pyrimidine derivatives

Also Published As

Publication number Publication date
WO2009036753A2 (en) 2009-03-26

Similar Documents

Publication Publication Date Title
WO2009068214A3 (en) Heteroaryl-substituted piperidines
ZA201001015B (en) (Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
IL181012A0 (en) Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments
IL204556A0 (en) (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
IL176913A0 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
WO2008046581A3 (en) Substituted tetrahydropyrrolopyrazine compounds and use thereof in medicaments
IL185804A0 (en) Aminocarbonyl-substituted 8-n-benzimidazoles, method for their production and their use as medicaments
WO2008089397A3 (en) Adrb2 cancer markers
IL180874A0 (en) Substituted, bicyclic 8-pyrrolidinoxanthines, method for the production thereof and their use as medicaments
WO2008054585A3 (en) Use of pegylated il-10 to treat cancer
ZA200805939B (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
WO2008135482A8 (en) Ionic liquids comprising polyethercarboxylates as anions, production and use thereof
HRP20130558T1 (en) 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and use thereof for treating diseases
WO2010078900A3 (en) Novel aliphatically substituted pyrazolopyridines, and the use thereof
IL195245A0 (en) Substituted prolinamides, production thereof and their use as drugs
IL179170A0 (en) Novel substituted thiophenecarboxamides, their production and their use as medicaments
WO2009071690A3 (en) 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases
IL193339A0 (en) Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
IL193341A0 (en) Novel azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
WO2009115252A3 (en) Substituted pyrazolamides and the use thereof
PL1718340T3 (en) New effector conjugates, process for their production and their pharmaceutical use
PT2225314T (en) Silicone-self-adhesives, method for the production thereof, complexes using same and uses
WO2007140804A8 (en) A process for the preparation of an oxaliplatin
WO2008110374A3 (en) Pellets containing a pharmaceutical substance, method for the production thereof and use of the same
SG148120A1 (en) An oral pharmaceutical and an oral care product

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08831840

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 08831840

Country of ref document: EP

Kind code of ref document: A2